Trastuzumab Biosimilars Demonstrate Equivalence Across Breast Cancer Settings

Hope S. Rugo, MD, discusses an analysis of trastuzumab biosimilars in breast cancer.

More From BioPortfolio on "Trastuzumab Biosimilars Demonstrate Equivalence Across Breast Cancer Settings"